2016 Short Courses

Three half day Short Courses will be held on Tuesday, March 8, 2016 from 12:30 PM - 5:30 PM.  These courses are focused on one particular topic and allow participants an additional opportunity to accrue CME and CEUs. An additional registration fee is required. Registration fees are:

 REGISTRATION CATEGORY ON OR BEFORE
DECEMBER 16, 2015
DECEMBER 17, 2015 to
JANUARY 27, 2016
JANUARY 28, 2016
to ONSITE  
 ACMG Member with Full Meeting  Registration 

$180

$230

$280

 Non-Member with Full Meeting  Registration

$230

$285

$330

 ACMG Member - Short Course Only  $230  $280  $330
 Non-Member - Short Course Only   $280  $335  $380



 

Advanced Molecular Cancer Genetics: State of the Art Today and Beyond
High-complexity molecular technologies widely used in cancer diagnosis, prognosis and therapy today include next generation sequencing (NGS) and chromosomal microarrays.  The goal of this session is to explore their current clinical applications, pros and cons, how germline findings inform cancer evaluation, and the relationship of clinically actionable mutations with molecular diagnostics as part of the precision medicine effort.  Finally, exciting innovations will be presented including using NGS to analyze cell-free circulating cancer DNA as well as the impact of the cancer epigenome.  This course is relevant for a diverse audience of genetics professionals including clinical geneticists, clinical and laboratory genetic counselors, laboratory directors, genetics fellows, genetic researchers and anyone else with some background in cancer genetics that have an interest in current and future molecular technologies and their clinical applications in cancer.
This activity is supported by an unrestricted educational grant from Illumina

Course Director:
Jenelle Hodge, PhD, FACMG, Cedars-Sinai Medical Center

Speakers:
Jenelle Hodge, PhD, FACMG, Cedars-Sinai Medical Center
Daynna Wolff, PhD, FACMG, Medical University of South Carolina
Nikhil Wagle, MD, Dana-Farber Cancer Institute, Broad Institute of Harvard and MIT
Colin Pritchard, MD, PhD, University of Washington
Sharon Plon, MD, PhD, Baylor College of Medicine
Trevor Pugh, PhD, FACMG, Princess Margaret Cancer Centre
Melanie Ehrlich, PhD, Tulane University School of Medicine



NAMA at the ACMG:  The Best of the North American Metabolic Academy
The North American Metabolic Academy is a philanthropically funded intensive metabolic training program for Medical Genetics residents.  In this session, faculty from NAMA will present a selection of tropics from the NAMA curriculum that will allow ACMG attendees to take advantage of this unique program to update key metabolic topics.  The program committee can choose from a list of more than 30 topics, selecting those that would be of greatest interest to the broader community of geneticists.  The proposed speakers and topics have been selected from recent NAMA meetings.  In the event one or more of these topics are also covered in another meeting session, another of the 30+ topics can be chosen as a replacement.

Course Directors:
Jerry Vockley, MD, PhD, University of Pittsburgh Medical Center
Mark Korson, MD, Genetic Metabolic Center for Education

Speakers:
Sylvia Stockler, MD, PhD, University of British Columbia British Columbia Children’s Hospital
Lynne Wolfe, MS, CRNP, National Institutes of Health / National Human Genome Research Institute
Michael Geraghty, MD, FACMG, FRCPC, Children's Hospital Eastern Ontario
Robert Steiner, MD, FACMG, Marshfield Clinic Research Foundation

 

Tools and Approaches to Assess the Genetic Basis of Disease 
The first half of the course will use OMIM as a catalyst to discuss the genetic contribution to disease, focusing on disease nosology, the changing definition of a gene and the many ways that OMIM can be used by clinicians, clinical laboratorians, counselors, basic and translational researchers and genomicists. The various features of the ClinGen and ClinVar resources will be presented including how these tools can support the translation of results from genomic sequencing tests into clinical medicine.

The second half of the course will focus a project completed by the Clinical Sequencing Exploratory Research (CSER) consortium to evaluate the ACMG variant interpretation guidelines. Nine CLIA genome/exome labs used both those guidelines and their local frameworks to classify the pathogenicity of 99 variants. Differences in variant interpretations within labs using ACMG vs. local criteria and among labs using each set of criteria will be discussed, as well as differences in how labs used the ACMG guidelines. We will discuss clarifications and limitations of variant classification.

Course Directors:
Laura Amendola, MS, CGC, University of Washington
Sue Richards, PhD, FACMG, Oregon Health and Science University

Speakers:
Ada Hamosh, MD, MPH, FACMG, Johns Hopkins School of Medicine
Robert Nussbaum, MD, UCSF
Sue Richards, PhD, FACMG, Oregon Health and Science University
Laura Amendola, MS, CGC, University of Washington
Yaping Yang, PhD, FACMG, Baylor Miraca Genetics Laboratories
Heidi Rehm, PhD, FACMG, Harvard Medical School and Partners Laboratory for Molecular Medicine
Gail Jarvik, MD, PhD, MS, FACMG, University of Washington
Leslie Biesecker, MD, FACMG, National Human Genome Research Institute

Jonathan Berg, MD, PhD, FACMG, University of North Carolina

More details on each Course including objectives, schedule and registration here.

Registration for ACMG 2017

Register will open in October 2016

March 21 - 25, 2017
Phoenix Convention Center
Phoenix, Arizona

Hotel Reservations

Reserve your room early to get the best choice.